Exploring the latest advances in axial spondyloarthritis management

Diego Benavent,Victoria Navarro-Compán
DOI: https://doi.org/10.1038/s41584-023-01072-7
IF: 32.286
2024-01-09
Nature Reviews Rheumatology
Abstract:Studies published in 2023 emphasize the long-term efficacy and safety of novel therapeutics for both radiographic and non-radiographic axial spondyloarthritis (axSpA) and provide a consensus definition of 'early axSpA' for use in research studies.
rheumatology
What problem does this paper attempt to address?